# Stanley Crooke
Meilleurs épisodes de podcast
Actualisé:
Top podcast episodes featuring stanley crooke.
Ionis CEO Stanley Crooke Discusses Success as a Platform Technology Company
As CEO of Ionis Pharmaceuticals, Stanley Crooke has been a pioneer in the development of antisense drugs and oversees one of the industry’s largest and most advanced pipelines. Antisense drugs are compelling for rare diseases because of their ability to selectively target specific RNA sequences. Th…
Driving N-of-1 Therapies for Ultra-Rare Disease Patients
Antisense pioneer and Ionis Pharmaceuticals Executive Chairman Stanley Crooke has launched a nonprofit to design and deliver custom RNA-targeted therapies free of charge for individual patients with ultra-rare diseases. The organization, n-Lorem Foundation, will leverage Ionis’ technology platform …
Helping the Patients He Can. For Free. For Life. - Stanley Crooke, MD, PhD
Imagine you are one of only 10 people in the world with a disease. People with ultra-rare conditions have little hope of attracting research funding to find treatments to work for them. The investments just don’t make sense to for-profit businesses.
Our guest, Dr. Stanley Crooke, MD, PHD is leadi…
#186 n-Lorem: Nano-Rare Diseases with Luke Rosen and Wendy Chung
We are thrilled to share a brand new podcast that Kira Dineen co-produces, the n-Lorem “Patient Empowerment Program”. The podcast just launched so we wanted to share the pilot episode with you! This podcast focuses solely, exclusively, on the needs of nano-rare patients. These are patients that hav…
123. Nano-rare patients & rare diseases, Stanley Crooke, Founder & CEO, n-Lorem Foundation
Synopsis:
Stanley Crooke is Founder and CEO of n-Lorem Foundation, a nonprofit with the goal of discovering, developing and providing experimental ASO treatments to nano-rare patients for free for life. He joins us for a discussion about the business model behind rare diseases and how n-Lorem is l…
Free for Life: The Story of n-Lorem Foundation
When patients face the diagnosis of a rare disease, they face a costly, uphill battle to develop a treatment for their condition… that is, if they ever do.
Dr. Stanley Crooke is aiming to change that. As the CEO of n-Lorem Foundation, his mission is to provide personalized treatments to ultra-r…
S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder
In today's episode, I am honored to welcome Stanley Crooke, the founder and CEO of Ionis Pharmaceuticals the first and leading antisense oligonucleotide biotech and founder, CEO and Chair of N-Lorem, a not for profit entity developing ASOs for ultra rare diseases. Stan is THE pioneer in the field o…
For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications
Roisin McGuigan, Commissioning Editor, Nucleic Acid Insights, speaks to Stanley Crooke, Chairman, Founder and CEO, n-Lorem, about his long career and pioneering role in the antisense oligonucleotide (ASO) space, how RNA-targeting therapies are set to enter the mainstream, and his latest focus: maki…
Personalized Drug Design: New Therapies for Rare Genetic Diseases with Dr. Stanley Crooke
Dr. Stanley Crooke pioneered a new class of medicine—antisense oligonucleotides—and built a $5B biotech company, Ionis Pharmaceuticals, to prove it could work. Then he walked away to found a nonprofit, n-Lorem, to treat patients with one-in-a-billion genetic mutations—people no one else would help.…
Genetic Mechanic: Stanley Crooke on Fixing Nano-Rare Disease with Oligos
In this episode of Dose of Discovery, hosts Søren and AJ speak to physician-scientist Stanley Crooke, CEO of the nonprofit n-Lorem Foundation, about how antisense oligonucleotide (ASO) technology has evolved into a revolutionary therapeutic modality.
Their conversation explores Stan's expansive car…
MOTEUR DE RECHERCHE DE PODCASTS
Vous pouvez utiliser notre site Web pour rechercher des podcasts3,820,646et des épisodes195,245,083par personnes, lieux ou sujets.
Investir dans le savoir offre le meilleur rendement, c'est pourquoi j'écoute des podcasts.
‐ Benjamin "Llamacorn" Franklin
MODIFIER
Merci de nous avoir aidé à tenir la base de données de podcasts à jour.
